Tongue Neurostimulation for Obstructive Sleep Apnea - MEDICAID - VIRGINIA

This policy addresses tongue neurostimulation (oral neuromuscular electrical stimulation devices — removable daytime tongue mouthpieces controlled by a smartphone app) as a treatment for obstructive sleep apnea and snoring. It is directed at Humana Medicaid members in Virginia, primarily for mild OSA (AHI <15) using a daytime regimen (≈20 minutes/day for 6 weeks then twice weekly), but the excerpt notes these HCPCS-coded devices (E0490–E0493, A9279) are considered not medically necessary for Humana members due to insufficient evidence, are not indicated for moderate–severe OSA, and coverage is subject to member contract and unspecified coverage limitations.

"Tongue neurostimulation as a treatment for obstructive sleep apnea (OSA)."

Sign up to see full coverage criteria, indications, and limitations.